Anne Starling
Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fluorocarbons | 21 | 2025 | 117 | 8.040 |
Why?
| | Prenatal Exposure Delayed Effects | 25 | 2025 | 605 | 6.000 |
Why?
| | Environmental Pollutants | 20 | 2025 | 159 | 5.490 |
Why?
| | Maternal Exposure | 20 | 2025 | 190 | 4.690 |
Why?
| | Alkanesulfonic Acids | 14 | 2025 | 41 | 3.810 |
Why?
| | Adiposity | 15 | 2024 | 518 | 3.050 |
Why?
| | Air Pollution | 6 | 2023 | 316 | 2.960 |
Why?
| | Phthalic Acids | 8 | 2025 | 40 | 2.930 |
Why?
| | Air Pollutants | 7 | 2024 | 430 | 2.890 |
Why?
| | DNA Methylation | 18 | 2025 | 643 | 2.560 |
Why?
| | Environmental Exposure | 15 | 2025 | 579 | 2.550 |
Why?
| | Pregnancy | 65 | 2025 | 6763 | 2.160 |
Why?
| | Phenols | 7 | 2025 | 99 | 1.920 |
Why?
| | Fetal Blood | 14 | 2024 | 327 | 1.850 |
Why?
| | Birth Weight | 17 | 2024 | 516 | 1.820 |
Why?
| | Drinking Water | 6 | 2025 | 84 | 1.580 |
Why?
| | Caprylates | 6 | 2025 | 25 | 1.410 |
Why?
| | Parabens | 4 | 2025 | 12 | 1.400 |
Why?
| | Water Pollutants, Chemical | 6 | 2025 | 215 | 1.390 |
Why?
| | Premature Birth | 8 | 2025 | 333 | 1.280 |
Why?
| | Pediatric Obesity | 6 | 2024 | 601 | 1.230 |
Why?
| | Epigenesis, Genetic | 13 | 2025 | 660 | 1.220 |
Why?
| | Endocrine Disruptors | 4 | 2025 | 42 | 1.180 |
Why?
| | Infant, Newborn | 38 | 2025 | 6079 | 1.110 |
Why?
| | Soot | 2 | 2024 | 26 | 1.100 |
Why?
| | Body Composition | 7 | 2023 | 684 | 0.960 |
Why?
| | Body Mass Index | 16 | 2023 | 2389 | 0.890 |
Why?
| | Child Development | 6 | 2025 | 475 | 0.870 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2111 | 0.860 |
Why?
| | Female | 75 | 2025 | 73304 | 0.860 |
Why?
| | Rubella | 1 | 2023 | 24 | 0.840 |
Why?
| | Mumps | 1 | 2023 | 25 | 0.840 |
Why?
| | Biomarkers | 13 | 2025 | 4149 | 0.820 |
Why?
| | Measles | 1 | 2023 | 46 | 0.820 |
Why?
| | Chickenpox | 1 | 2023 | 83 | 0.800 |
Why?
| | Particulate Matter | 6 | 2023 | 315 | 0.800 |
Why?
| | Organophosphates | 5 | 2025 | 134 | 0.790 |
Why?
| | Adiponectin | 1 | 2024 | 244 | 0.780 |
Why?
| | Child, Preschool | 27 | 2025 | 11074 | 0.760 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 4 | 2021 | 59 | 0.730 |
Why?
| | Vaccines | 2 | 2023 | 406 | 0.720 |
Why?
| | Humans | 88 | 2025 | 137585 | 0.700 |
Why?
| | Bayes Theorem | 7 | 2023 | 405 | 0.690 |
Why?
| | Flame Retardants | 3 | 2025 | 11 | 0.680 |
Why?
| | Infant | 22 | 2025 | 9465 | 0.660 |
Why?
| | Asthma | 5 | 2025 | 2295 | 0.640 |
Why?
| | Cohort Studies | 19 | 2025 | 5742 | 0.630 |
Why?
| | Vehicle Emissions | 1 | 2020 | 67 | 0.630 |
Why?
| | Prospective Studies | 19 | 2025 | 7604 | 0.620 |
Why?
| | Child | 33 | 2025 | 21935 | 0.620 |
Why?
| | Weight Gain | 5 | 2017 | 519 | 0.600 |
Why?
| | Adult | 39 | 2025 | 37929 | 0.590 |
Why?
| | Pesticides | 2 | 2019 | 62 | 0.570 |
Why?
| | Obesity | 13 | 2023 | 2992 | 0.560 |
Why?
| | Mothers | 7 | 2023 | 754 | 0.540 |
Why?
| | Diabetes, Gestational | 4 | 2024 | 318 | 0.530 |
Why?
| | Tobacco Smoke Pollution | 4 | 2022 | 261 | 0.530 |
Why?
| | Blood Glucose | 3 | 2024 | 2186 | 0.520 |
Why?
| | Linear Models | 7 | 2019 | 849 | 0.510 |
Why?
| | Infant, Small for Gestational Age | 1 | 2017 | 92 | 0.500 |
Why?
| | Child Health | 5 | 2025 | 154 | 0.470 |
Why?
| | Stress, Physiological | 2 | 2009 | 443 | 0.470 |
Why?
| | Lemur | 2 | 2019 | 52 | 0.460 |
Why?
| | Pre-Eclampsia | 2 | 2014 | 190 | 0.460 |
Why?
| | Diet | 6 | 2023 | 1278 | 0.440 |
Why?
| | CpG Islands | 6 | 2024 | 157 | 0.440 |
Why?
| | Adipose Tissue | 6 | 2022 | 635 | 0.430 |
Why?
| | Diethylhexyl Phthalate | 2 | 2024 | 15 | 0.430 |
Why?
| | Agricultural Workers' Diseases | 1 | 2014 | 31 | 0.420 |
Why?
| | Child Behavior | 2 | 2025 | 248 | 0.400 |
Why?
| | Genome-Wide Association Study | 8 | 2025 | 1431 | 0.400 |
Why?
| | Spouses | 1 | 2014 | 105 | 0.400 |
Why?
| | Colorado | 13 | 2024 | 4565 | 0.400 |
Why?
| | Young Adult | 16 | 2025 | 13209 | 0.380 |
Why?
| | Pregnancy Complications | 4 | 2024 | 527 | 0.380 |
Why?
| | Esters | 4 | 2025 | 76 | 0.380 |
Why?
| | Male | 34 | 2025 | 67762 | 0.360 |
Why?
| | Plasticizers | 2 | 2024 | 15 | 0.340 |
Why?
| | Occupational Exposure | 1 | 2014 | 341 | 0.330 |
Why?
| | Sex Characteristics | 2 | 2019 | 762 | 0.330 |
Why?
| | Lipids | 2 | 2015 | 672 | 0.320 |
Why?
| | Diabetes Mellitus | 2 | 2019 | 1040 | 0.320 |
Why?
| | Environmental Monitoring | 5 | 2025 | 370 | 0.320 |
Why?
| | Blood Pressure | 1 | 2017 | 1786 | 0.320 |
Why?
| | Seasons | 2 | 2023 | 547 | 0.300 |
Why?
| | Dental Enamel Hypoplasia | 1 | 2007 | 7 | 0.280 |
Why?
| | Longitudinal Studies | 9 | 2025 | 2844 | 0.280 |
Why?
| | Reproduction | 1 | 2009 | 204 | 0.280 |
Why?
| | Plethysmography | 6 | 2018 | 106 | 0.280 |
Why?
| | Norway | 4 | 2014 | 43 | 0.270 |
Why?
| | Phenol | 2 | 2023 | 19 | 0.260 |
Why?
| | Agriculture | 1 | 2007 | 103 | 0.260 |
Why?
| | Adolescent | 14 | 2025 | 21513 | 0.260 |
Why?
| | Social Dominance | 2 | 2019 | 21 | 0.240 |
Why?
| | Glucocorticoids | 1 | 2009 | 594 | 0.230 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 5472 | 0.230 |
Why?
| | Carbon | 2 | 2023 | 216 | 0.230 |
Why?
| | Vaccination | 2 | 2023 | 1381 | 0.220 |
Why?
| | Incidence | 3 | 2023 | 2804 | 0.220 |
Why?
| | Maternal Health | 3 | 2024 | 49 | 0.220 |
Why?
| | Chlorophenols | 1 | 2023 | 9 | 0.220 |
Why?
| | Groundwater | 1 | 2024 | 40 | 0.220 |
Why?
| | Benzophenones | 1 | 2023 | 16 | 0.210 |
Why?
| | Sex Factors | 4 | 2025 | 2071 | 0.210 |
Why?
| | Maternal Nutritional Physiological Phenomena | 4 | 2023 | 176 | 0.210 |
Why?
| | Biphenyl Compounds | 1 | 2024 | 63 | 0.210 |
Why?
| | Alkanesulfonates | 1 | 2023 | 8 | 0.210 |
Why?
| | Carboxylic Acids | 1 | 2023 | 34 | 0.200 |
Why?
| | Appetite | 1 | 2023 | 69 | 0.200 |
Why?
| | Insulin | 2 | 2024 | 2409 | 0.200 |
Why?
| | Smoking | 3 | 2019 | 1627 | 0.200 |
Why?
| | Arsenic | 1 | 2023 | 64 | 0.200 |
Why?
| | Health Status | 1 | 2007 | 792 | 0.190 |
Why?
| | Cotinine | 2 | 2022 | 77 | 0.190 |
Why?
| | Metalloids | 1 | 2022 | 1 | 0.190 |
Why?
| | Antibody Formation | 1 | 2023 | 298 | 0.190 |
Why?
| | Glucose | 2 | 2017 | 1020 | 0.190 |
Why?
| | Depression, Postpartum | 1 | 2024 | 132 | 0.180 |
Why?
| | Diet, Mediterranean | 1 | 2022 | 30 | 0.180 |
Why?
| | Breast Feeding | 4 | 2018 | 440 | 0.180 |
Why?
| | Ozone | 1 | 2022 | 132 | 0.180 |
Why?
| | Energy Intake | 3 | 2023 | 485 | 0.180 |
Why?
| | Educational Status | 1 | 2023 | 470 | 0.180 |
Why?
| | Pregnancy Trimester, Second | 2 | 2021 | 80 | 0.170 |
Why?
| | Metals | 1 | 2022 | 136 | 0.170 |
Why?
| | Proportional Hazards Models | 2 | 2014 | 1266 | 0.170 |
Why?
| | Overweight | 2 | 2023 | 558 | 0.170 |
Why?
| | Parturition | 1 | 2020 | 71 | 0.160 |
Why?
| | Chemokines | 1 | 2021 | 228 | 0.160 |
Why?
| | Water Pollution | 1 | 2019 | 9 | 0.160 |
Why?
| | Androstenedione | 1 | 2019 | 11 | 0.160 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2023 | 279 | 0.160 |
Why?
| | Sexual Maturation | 1 | 2019 | 55 | 0.150 |
Why?
| | Overnutrition | 1 | 2019 | 30 | 0.150 |
Why?
| | Family | 1 | 2023 | 671 | 0.150 |
Why?
| | Sleep Wake Disorders | 1 | 2022 | 286 | 0.150 |
Why?
| | Food Hypersensitivity | 1 | 2021 | 183 | 0.150 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2019 | 69 | 0.150 |
Why?
| | Insulin Resistance | 2 | 2024 | 1208 | 0.140 |
Why?
| | Gestational Age | 4 | 2025 | 910 | 0.140 |
Why?
| | Body Fluid Compartments | 1 | 2017 | 6 | 0.140 |
Why?
| | Aggression | 1 | 2019 | 202 | 0.140 |
Why?
| | Benzhydryl Compounds | 1 | 2018 | 73 | 0.140 |
Why?
| | Diet Records | 1 | 2017 | 83 | 0.130 |
Why?
| | Hyperglycemia | 1 | 2021 | 347 | 0.130 |
Why?
| | United States | 9 | 2025 | 14841 | 0.130 |
Why?
| | Neurodevelopmental Disorders | 1 | 2019 | 181 | 0.130 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 416 | 0.130 |
Why?
| | Genome, Human | 1 | 2019 | 425 | 0.130 |
Why?
| | Pregnancy Trimester, Third | 1 | 2017 | 114 | 0.130 |
Why?
| | Glucose Metabolism Disorders | 1 | 2016 | 11 | 0.130 |
Why?
| | Research Design | 1 | 2023 | 1139 | 0.130 |
Why?
| | Body Weight | 2 | 2017 | 985 | 0.120 |
Why?
| | Behavior, Animal | 1 | 2019 | 501 | 0.120 |
Why?
| | Blood Pressure Determination | 1 | 2017 | 157 | 0.120 |
Why?
| | Healthy Lifestyle | 1 | 2016 | 34 | 0.120 |
Why?
| | Choristoma | 1 | 2015 | 21 | 0.120 |
Why?
| | Risk Factors | 7 | 2019 | 10388 | 0.120 |
Why?
| | Fasting | 1 | 2017 | 281 | 0.120 |
Why?
| | Testosterone | 1 | 2019 | 409 | 0.120 |
Why?
| | China | 1 | 2015 | 217 | 0.110 |
Why?
| | Health Surveys | 1 | 2017 | 514 | 0.110 |
Why?
| | Infant, Premature | 1 | 2019 | 574 | 0.110 |
Why?
| | Risk Management | 1 | 2015 | 93 | 0.110 |
Why?
| | Infant, Newborn, Diseases | 1 | 2016 | 113 | 0.110 |
Why?
| | Smoking Cessation | 1 | 2018 | 442 | 0.110 |
Why?
| | Iowa | 1 | 2014 | 30 | 0.110 |
Why?
| | Vitamins | 1 | 2015 | 185 | 0.110 |
Why?
| | Socioeconomic Factors | 2 | 2019 | 1289 | 0.110 |
Why?
| | North Carolina | 1 | 2014 | 110 | 0.110 |
Why?
| | Alkanes | 1 | 2013 | 13 | 0.110 |
Why?
| | Parity | 1 | 2014 | 126 | 0.100 |
Why?
| | Creatinine | 1 | 2015 | 499 | 0.100 |
Why?
| | Thyrotropin | 1 | 2013 | 114 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1509 | 0.100 |
Why?
| | Cytokines | 1 | 2021 | 2085 | 0.100 |
Why?
| | Fetal Development | 3 | 2024 | 296 | 0.100 |
Why?
| | Urban Population | 1 | 2015 | 479 | 0.100 |
Why?
| | DNA | 1 | 2019 | 1459 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2531 | 0.090 |
Why?
| | Phosphates | 2 | 2024 | 182 | 0.090 |
Why?
| | Nutrition Surveys | 2 | 2024 | 266 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1502 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1153 | 0.090 |
Why?
| | Logistic Models | 1 | 2017 | 2074 | 0.090 |
Why?
| | Cholesterol | 1 | 2013 | 410 | 0.090 |
Why?
| | Dietary Supplements | 1 | 2015 | 561 | 0.090 |
Why?
| | Fatty Acids | 1 | 2014 | 443 | 0.090 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3284 | 0.080 |
Why?
| | Aged | 4 | 2024 | 23961 | 0.080 |
Why?
| | Mental Health | 1 | 2016 | 726 | 0.080 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 1040 | 0.080 |
Why?
| | Maternal-Fetal Exchange | 1 | 2009 | 165 | 0.070 |
Why?
| | Corticosterone | 1 | 2009 | 236 | 0.070 |
Why?
| | Egypt, Ancient | 1 | 2007 | 2 | 0.070 |
Why?
| | Middle Aged | 4 | 2025 | 33479 | 0.070 |
Why?
| | Paleodontology | 1 | 2007 | 13 | 0.070 |
Why?
| | History, Ancient | 1 | 2007 | 54 | 0.070 |
Why?
| | Social Environment | 1 | 2009 | 296 | 0.070 |
Why?
| | Folic Acid | 2 | 2019 | 186 | 0.070 |
Why?
| | Hydrocortisone | 1 | 2009 | 322 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2019 | 7635 | 0.060 |
Why?
| | Feces | 1 | 2009 | 484 | 0.060 |
Why?
| | Registries | 1 | 2014 | 2035 | 0.060 |
Why?
| | Odds Ratio | 2 | 2022 | 1070 | 0.060 |
Why?
| | Circadian Rhythm | 1 | 2009 | 468 | 0.060 |
Why?
| | Pregnancy Trimesters | 1 | 2025 | 19 | 0.060 |
Why?
| | Software | 2 | 2023 | 665 | 0.060 |
Why?
| | Feeding Behavior | 2 | 2023 | 654 | 0.060 |
Why?
| | Epigenomics | 1 | 2025 | 115 | 0.060 |
Why?
| | Exercise | 1 | 2016 | 2057 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2025 | 186 | 0.050 |
Why?
| | Appetitive Behavior | 1 | 2023 | 9 | 0.050 |
Why?
| | Satiation | 1 | 2023 | 24 | 0.050 |
Why?
| | Netherlands | 1 | 2023 | 88 | 0.050 |
Why?
| | Appetite Regulation | 1 | 2023 | 31 | 0.050 |
Why?
| | Toxicokinetics | 1 | 2023 | 9 | 0.050 |
Why?
| | Academic Success | 1 | 2023 | 29 | 0.050 |
Why?
| | Connectome | 1 | 2024 | 86 | 0.050 |
Why?
| | Environment Design | 1 | 2023 | 27 | 0.050 |
Why?
| | Sugars | 1 | 2023 | 41 | 0.050 |
Why?
| | Sample Size | 1 | 2023 | 125 | 0.050 |
Why?
| | Models, Biological | 1 | 2009 | 1783 | 0.050 |
Why?
| | Cytosine | 1 | 2022 | 49 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2014 | 5778 | 0.050 |
Why?
| | Adipogenesis | 1 | 2022 | 55 | 0.050 |
Why?
| | Guanine | 1 | 2022 | 79 | 0.050 |
Why?
| | Carcinogenesis | 1 | 2023 | 217 | 0.050 |
Why?
| | Risk Assessment | 2 | 2024 | 3457 | 0.050 |
Why?
| | Immunization Schedule | 1 | 2022 | 197 | 0.040 |
Why?
| | Tobacco Products | 1 | 2022 | 138 | 0.040 |
Why?
| | Serum | 1 | 2021 | 59 | 0.040 |
Why?
| | Glycation End Products, Advanced | 1 | 2021 | 82 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3295 | 0.040 |
Why?
| | Immunization | 1 | 2022 | 411 | 0.040 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2021 | 43 | 0.040 |
Why?
| | Respiratory Sounds | 1 | 2021 | 125 | 0.040 |
Why?
| | Residence Characteristics | 1 | 2023 | 351 | 0.040 |
Why?
| | Environmental Health | 1 | 2020 | 48 | 0.040 |
Why?
| | Dust | 1 | 2020 | 100 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 366 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2019 | 3556 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2021 | 377 | 0.040 |
Why?
| | Demography | 1 | 2019 | 291 | 0.040 |
Why?
| | Environmental Pollution | 1 | 2018 | 20 | 0.040 |
Why?
| | Animals | 3 | 2023 | 36940 | 0.040 |
Why?
| | Walking | 1 | 2023 | 529 | 0.040 |
Why?
| | Fetal Growth Retardation | 1 | 2023 | 565 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2017 | 195 | 0.030 |
Why?
| | Anthropometry | 1 | 2017 | 213 | 0.030 |
Why?
| | Body Height | 1 | 2017 | 199 | 0.030 |
Why?
| | Transcription Factors | 1 | 2024 | 1719 | 0.030 |
Why?
| | Diet Surveys | 1 | 2016 | 95 | 0.030 |
Why?
| | Sleep | 1 | 2022 | 755 | 0.030 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2015 | 159 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2017 | 1316 | 0.030 |
Why?
| | Nutritional Status | 1 | 2017 | 350 | 0.030 |
Why?
| | Fetus | 1 | 2019 | 806 | 0.030 |
Why?
| | Physical Endurance | 1 | 2015 | 275 | 0.030 |
Why?
| | Autism Spectrum Disorder | 1 | 2019 | 395 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2018 | 766 | 0.030 |
Why?
| | Risk | 1 | 2016 | 912 | 0.030 |
Why?
| | Immunoassay | 1 | 2013 | 115 | 0.020 |
Why?
| | Inflammation | 1 | 2023 | 2837 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 518 | 0.020 |
Why?
| | Athletes | 1 | 2015 | 423 | 0.020 |
Why?
| | Self Report | 1 | 2016 | 827 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2031 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 597 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2013 | 532 | 0.020 |
Why?
| | Metabolomics | 1 | 2015 | 678 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1946 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3566 | 0.020 |
Why?
| | Mice | 1 | 2023 | 17787 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1724 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 10811 | 0.010 |
Why?
|
|
Starling's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|